NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

复旦大学附属中山医院葛均波院士团队在11万余ST段抬高型心肌梗死（STEMI）患者中进行的研究表明，当前EMS呼叫延迟中位时间为46分钟，老年人、女性、夜间发病 （00:00~05:59）及非持续性胸痛/胸闷患者更可能延迟。

Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an approximately 21% reduction in a patient's risk of ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...

A study was conducted to examine the predictive performance of an AI ECG algorithm for identifying occlusive myocardial infarction.

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...

Patients receiving oral niacinamide for nonmelanoma skin cancer chemoprophylaxis show fewer cardiac events, a retrospective ...

This news was covered by the Medical Dialogues Bureau, which was present at the TCT Conference 2025 held in San Francisco, ...